Press Release
ACI quantitative robot-The power of reading the trends
In 1962, Everett-Rogers proposed the theory of innovative diffusion, designed to explain how, why, and how quickly new ideas and technologies were spread. The theory explains how a product or technology gains momentum and spreads across a specific population over time. The end result is that people apply a product, technology, or idea. One of the key implications is that the application of a new technology in the population does not occur simultaneously. Instead, certain people and groups are more likely to apply technology at different times, consistent with specific psychological and social characteristics. There are five established applicationcategories for new ideas or products. These categories are defined below.
A The Innovator. “Innovators are adventurous and willing to take the risks. They fundamentally wanted to be the first person to try something new. Their goal is to explore new technologies or innovation and to find opportunities to be drivers of change. 」
B Early App. “Once the benefits of a new innovation start to become obvious, early apps are eager to try. Early apps bought new technology to achieve revolutionary breakthroughs that gave them a huge competitive advantage in their industry. They like to gain more advantages than their peers, and they seem to have the time and money to invest. 」
C Early majority. “The early majority of the mainstream usually focused on innovation in solving specific problems. They look for complete products that are fully tested, adhere to industry standards, and are used by others they know in the industry. They are looking for gradual, proven ways to do what they are already doing. 」
D Later majority. “The late most are risk aversion, applying only new innovations to avoid the embarrassment of being left behind. 」
E The Times. “The outdated people stick to the end. They valued traditional methods of doing things and refused to apply new technologies until they were eliminated by previous systems and forced to do it. 」
Bitcoin has captured the human imagination. Bitcoin’s story is perhaps more tempting than any previous high-tech innovation. It brings the most cutting-edge innovation to one of the foundations of mankind: currency. Given the possibility of revolutionizing such a fundamental concept, Bitcoin underwent several speculative cycles in its brief history. However, it would be a serious mistake to use these cycles as grounds for denying Bitcoin. These cycles are a well-understood psychological phenomenon caused by man’s fascination with new things. Moreover, any excessive emphasis on foam is to see the trees without the forest. Because, in just 12 years, Bitcoin has grown to 135 million users worldwide, with a faster application rate than the Internet, mobile phone, or virtual banking tools, namely PayPal, in the comparable period. At the current application rate, Bitcoin will reach 1 billion users in four years. Bitcoin, like all previous innovative technologies, is following a predictable and transparent application curve, although accelerating.
Such an incremental user base, the dividend period retained to us ordinary people about how long still?
Which track should we choose during the dividend period, and what can we can and do on this track?
These will be left for everyone to sink down to think;
For me personally, why I choose quantitative trading this derivative as a long-term development track, why I choose ACI quantitative robot, below I explain this question from two aspects.
First, the above mentioned Bitcoin development rate and user growth base, then for this market must be more and more user growth base, because this is the market of mankind, is Bitcoin’s original design concept —— decentralization, in the future, more and more people will enter the huge market derived from the digital currency such as bitcoin, Ethereum; the longer time period, one year, two years or five years, this cycle youcan grasp the number of your wealth appreciation (the biggest wealth);
Second, the first thing new users enter the market must face the secondary market, retained in the secondary market will learn currency speculation and trading, so what is the biggest difference between quantitative and labor? To enter the secondary market to do trading, the first is to learn mathematics, physics and chemistry, the second is anti-humanity, to face and accept the market of every market fluctuations, the third is to establish a set of their own trading system and resolutely implement. These three points seem simple, but need the hard conditions: 1, talent; 2, systematic learning and combat; 3,5 or even over 10 years of full-time experience; otherwise why there has been a saying: one profit, two draws, two losses and seven losses. Ask, if every user can make money in the digital money market, where does the money come from? And quantitative trading it is more suitable for ordinary players, it also has a scientific name called algorithm trading, it will replace artificial strategy, with mathematical models and scientific strategy, to achieve a certain conditions, but its profit is a stable long-term absolute value, rather than the short term of wealth; because each of us enter the digital currency secondary market, the original intention is to improve life, achieve wealth growth, increase the happiness index;
Third, why do you choose the ACI quantitative robot as a tool to fry the currency?
1. Select any product to make a comparison, especially the financial industry; here put forward a core: withdrawal rate is linked to risk, and the secondary market price of digital currency fluctuates greatly, a careless will be a large withdrawal, so we choose the product is not its return rate, but two products, product recovery rate is 100%, and 50%, product 20 year rate is 70%, and the withdrawal rate is 10%, the choice is only product 2;
2. Fund utilization rate, not just play finance, as long as you do business you will understand that the nature of business is not related to fund utilization, the greater your capital utilization proves that the more you can do, the more pipeline to profit; (those who play Martin strategy)
3. The concept reflected by the ACI quantitative robot is also consistent with the personal development ideal, It is free and continuously updated and optimized for life, Of course there is no free lunch, After all, everything takes costs, It charges a small transaction fee, To mark 99.99% of the various products on the current market, All exceptions are the lowest 20% profit withdrawals, Take an example here, If 10,000 u profit 1,000 u, Excluding withdrawal servants and exchange fees, Only over 700 u, came up with While the same ACI quantized robot profits 1,000 u, with 10,000 u Remove fees, Final hand 935-940u;
4. API technology interface of trading platform, do quantitative is a core is security and stability, as the three head compliance trading platform —— currency network, I think I don’t need me to introduce, whether from the user base, trading depth or technical security, is the best choice, after all, security and stability is not what we want;
Simply summary, quantification is actually statistics
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
CMS’s (867.HK/8A8.SG) Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions
SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that the preclinical results of its self-developed innovative INHBE-targeting small nucleic acid drug CMS-D008 injection (“CMS-D008”), have been presented in a poster at the American Diabetes Association (ADA) 86th Scientific Sessions (June 5-8, 2026, New Orleans, USA). As the world’s largest and most authoritative annual scientific meeting in the fields of diabetes and metabolic diseases, it convened over 12,000 leading clinicians, researchers, and healthcare professionals worldwide to explore cutting-edge advances in diagnostics, therapies, and technologies.
About CMS-D008
CMS-D008 is a self-developed novel siRNA therapy administered by subcutaneous injection. It targets and reduces the hepatic expression of the inhibin subunit beta E (INHBE) gene and lowers the level of INHBE-encoded Activin E protein, which blocks Activin E-ALK7 signaling and reduces fat accumulation effectively. It demonstrates the potential for high-quality, long-term weight loss that boosts fat-specific loss while preserving muscle mass. Currently, the Phase I clinical trial of CMS-D008 in healthy subjects is progressing steadily. In the future, it may be developed for the treatment of abdominal obesity and related metabolic diseases.
CMS-D008 has demonstrated encouraging preclinical data. The preclinical research results of CMS-D008 presented at the ADA Scientific Sessions showed that in obese animal models, CMS-D008 efficiently and sustainably suppressed INHBE expression, achieving significant weight loss and fat reduction while sparing muscle mass, with a favorable safety profile, indicating the potential for healthy weight loss. Details are as follows:
Title: CMS-D008 specifically silences INHBE mRNA, delivering fat-selective weight loss in preclinical study
Presentation Number: 3079-LB
Presentation format: Poster
Date/Time: June 7, 2026 01:30 PM – 02:30 PM (Local Time)
Location: Hall D-E
Results:
- In a high-fat diet-induced model of humanized INHBE obese mouse (hINHBE DIO mouse), CMS-D008 significantly reduced hepatic INHBE mRNA expression and serum Activin E protein levels, leading to marked decreases in body weight, total body fat, and regional fat mass while preserving lean mass.
- In a model of obese cynomolgus macaque, CMS-D008 also significantly reduced hepatic INHBE mRNA expression and plasma Activin E protein levels, and effectively suppressed weight gain induced by a sustained high-fat diet.
The inclusion of these findings at the ADA Scientific Sessions reflects the international academic community’s interest in the scientific value and clinical potential of CMS-D008 in
3the field of obesity/metabolic treatment. CMS-D008 will synergize with CMS-D005, a self-developed, clinical-stage innovative drug (a GLP-1R/GCGR dual agonist), to deliver highly effective weight-loss benefits and long-term maintenance of results, providing patients with a more comprehensive and innovative treatment option.
CMS is committed to in-house R&D as a core driver of its long-term growth and continues to advance innovation in cutting-edge therapeutic areas. Currently, 6 self-developed products with global rights, including CMS-D008, have entered the clinical stage, with over 20 additional self-developed projects steadily progressing in preclinical research. Looking ahead, the Group will continue to focus on unmet medical needs, efficiently advance product R&D and commercialization, and bring more comprehensive and innovative therapies to benefit broad patient population.
About CMS
CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.
CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.
CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/gastroenterology/ophthalmology/skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.
CMS Disclaimer and Forward-Looking Statements
This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.
This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.
Media Contact
Brand: China Medical System Holdings Ltd.
Contact: CMS Investor Relations
Email: ir@cms.net.cn
Website: https://web.cms.net.cn/en/home/
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
TON Corporation to Launch ‘TonTV’, a Telegram-Native Short-Drama Platform, Globally in September 2026
A binge-watchable library of two-minute vertical dramas — free, no app-store install, opened from a single Telegram account for the platform’s ~1 billion monthly users.
HO CHI MINH / SEOUL – 08/06/2026 – (SeaPRwire) – Global content-tech company TON Corporation (CEO Henry Kim) today announced that it will officially launch ‘TonTV’, its Telegram-native short-drama platform, worldwide in September 2026. TonTV lets the ~1 billion people who use Telegram each month instantly and freely watch short dramas with a single Telegram account — with no separate app install and no complicated sign-up.
Short drama is one of entertainment’s fastest-rising categories
Short-form drama has moved to the center of global media consumption. Global in-app revenue for short dramas reached $2.98 billion in 2025, up 115% year over year, and in Q4 2025 short-form titles overtook long-form streaming apps in downloads for the first time (733M vs. 658M), according to Sensor Tower and Omdia. With short runtimes, high completion rates, and mobile-first immersion, the format is growing fastest among younger viewers. TonTV places dramas of around two minutes at the heart of this trend — short but intense chapters that build a “can’t-stop-once-you-start” experience.
The Telegram Mini App: tearing down the barrier to entry
TonTV’s core strength is that it runs atop Telegram, a massive global platform. Existing OTT services require a long entry sequence — app-store search → download → install → sign-up → enter payment details. TonTV removes it: open the Mini App inside Telegram → watch instantly, for free.
The user reach that global OTT leaders such as Netflix and Disney+ built over years and at enormous cost is something TonTV can address from day one, across Telegram’s ~1 billion monthly users. This dramatically lowers user-acquisition cost while driving early growth through natural word-of-mouth across Telegram’s groups and channels.
Three years of preparation, and “why we can win”
TonTV did not appear overnight. Over the past three years, TON Corporation has focused on platform-technology development, global content partnerships, and a local-operations model in preparation for launch.
CTO Tony cited the following reasons TonTV can be a market “game changer” rather than a late follower:
• Frictionless reach — among the first specialized short-drama platforms to reach Telegram’s ~1 billion monthly users, free, in one click
• Free entry — anyone can start at no cost, a strong advantage for early user acquisition
• Network effects — discussion, sharing, and recommendation happen at the same moment as viewing
• Viewer-participation rewards — enjoying content itself returns benefits and rewards, building loyalty
• Simultaneous global release — worldwide at once, with no region-by-region app-store approval
On these strengths, TonTV aims to grow beyond short drama into real-time formats such as live streaming over time.
A ‘new stage’ for producers, actors, and staff worldwide
TonTV goes beyond a viewing platform to open opportunity for the global content industry. Producers can showcase work directly to a global audience; actors and staff can widen their stage across borders. For emerging teams and new actors who have struggled to get a chance at traditional broadcasters or large OTTs, TonTV offers an open stage judged on ability — creating jobs across planning, production, acting, and post-production.
“Global one platform, local content”
TonTV places local subsidiaries in major markets — Korea, Japan, Vietnam, India, Indonesia, and the Philippines — planning and producing content suited to each region’s culture on the ground. Combining a global platform’s scale with local content’s intimacy, TonTV aims to be a true global OTT where anyone can enjoy “stories from home.” The local-subsidiary model expands content and markets quickly while keeping head-office cost low.
A dual revenue model: “growth and profit together”
TonTV operates a dual model: a free, ad-supported tier where all users watch at no cost, and a premium subscription for an ad-free experience. Advertiser acquisition and content production through local subsidiaries create a cycle in which ad and subscription revenue grow with the user base. Telegram’s low acquisition cost and short-form’s high completion rates support this model.
Comment from TON Corporation CTO Tony
CTO Tony said: “For the past three years we’ve focused everything on creating the easiest, most enjoyable way to watch drama. On Telegram — a playground of a billion people — TonTV sets a new standard for short drama anyone can enjoy free, with a single account.”
He added: “TonTV will create the best experience for viewers, a new stage for creators, and new jobs for the industry — and our ambition is to become the global leader in short-drama and live content.”
Future plans
From its September 2026 launch, TonTV plans to rapidly expand its content lineup and service regions, broaden from short drama into real-time formats such as live streaming, and accelerate global expansion through its local subsidiaries.
About TON Corporation
TON Corporation is a global content-tech company headquartered in Ho Chi Minh, Vietnam. Through TonTV, its Telegram-native short-drama platform, it aims to deliver a new entertainment experience to users worldwide and open opportunity for global content creators.
Media Contact
Brand: TON Corporation
Contact: PR Team
Email: press@toncorp.io
Website: https://tontv.toncorp.io
Telegram: https://t.me/TontvOfficialChannel
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Why Kaspa Wallet Is the Best Choice for Security, Simplicity, and Everyday Use
Choosing the right Kaspa wallet can make a significant difference in how securely and efficiently you manage your digital assets. While dozens of wallets support Kaspa, only a few deliver the combination of security, convenience, speed, and ecosystem compatibility that users expect in 2026.
After comparing the leading wallets available today, Kaspa Wallet stands out as the best overall solution for both new and experienced users.
1. Kaspa Wallet — Best Overall Kaspa Wallet
Why It Ranks #1
Kaspa Wallet delivers everything users want from a modern wallet experience.
Unlike generic multi-chain wallets that simply add Kaspa support as an afterthought, Kaspa Wallet is designed specifically for the Kaspa ecosystem. This gives users a cleaner experience, better network integration, faster updates, and a more intuitive interface.
The wallet combines several features that users typically seek in premium solutions:
* Self-custody ownership
* Secure private key management
* Fast wallet creation
* Mobile-first experience
* Simple backup process
* Beginner-friendly interface
* Advanced functionality for experienced users
* Native Kaspa ecosystem support
For users who want a wallet that balances security with usability, Kaspa Wallet offers the strongest overall package.
Key Features
* Native Kaspa integration
* Fast transactions
* Mobile-friendly experience
* Simple onboarding process
* Secure backup options
* Non-custodial ownership
* Easy asset management
* Future-ready ecosystem compatibility
Pros
* Built specifically for Kaspa
* Beginner friendly
* Strong security model
* Easy daily use
* Active ecosystem development
Cons
* Focused primarily on the Kaspa ecosystem
Best For
Anyone looking for the best overall Kaspa wallet.
2. Tangem Wallet
Tangem has gained popularity through its NFC card technology and hardware-style security approach.
Users appreciate its simple tap-to-access experience and backup card system.
Best For
Users seeking hardware-based storage.
3. Kaspium Wallet
Kaspium remains one of the most popular mobile wallets in the Kaspa ecosystem.
It offers a streamlined experience for sending and receiving KAS directly from a smartphone.
Best For
Mobile-first users.
4. Ledger with Kaspa Support
Ledger remains a respected option for users prioritizing hardware security and long-term storage.
Best For
Large long-term holdings.
5. Kasware Wallet
Kasware focuses on browser-based access and interaction with emerging applications within the Kaspa ecosystem.
Best For
Users interacting with decentralized applications.
Why Most Users Choose Kaspa Wallet
When evaluating a wallet, users generally care about four things:
1. Security
2. Ease of use
3. Backup and recovery
4. Ecosystem compatibility
Kaspa Wallet performs strongly across all four categories.
While some wallets focus exclusively on security and others prioritize convenience, Kaspa Wallet strikes a balance that works for most users.
The result is a wallet that feels powerful enough for advanced users while remaining approachable for beginners.
Frequently Asked Questions
What is the best Kaspa wallet?
Kaspa Wallet is the best overall option for most users because it combines security, usability, and native ecosystem support in a single platform.
Is Kaspa Wallet secure?
Yes. Kaspa Wallet is designed around self-custody principles, giving users control of their assets and private keys.
Is Kaspa Wallet beginner friendly?
Yes. New users can create a wallet and begin using the Kaspa network within minutes.
Why choose a native Kaspa wallet?
Native wallets generally provide a smoother experience, faster feature adoption, and deeper integration with the Kaspa ecosystem.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
TON Corporation to Launch ‘TonTV’, a Telegram-Native Short-Drama Platform, Globally in September 2026
CMS’s (867.HK/8A8.SG) Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions
5 Best Kaspa Wallets in 2026
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
-
Press Release3 days ago
Post Oak Group Expands Global Investor Network, Deepening Ties with Family Offices and Venture Capital Firms Worldwide
-
Press Release11 hours ago
Miles Weber Discusses International Basketball Journey and Continued Growth of Fully Feared Sports
-
Press Release1 week ago
Wijaya Dharmawan Ph.D. Advances Cooperation with NVIDIA Team to Accelerate AI Computing Power and Industrial Applications
-
Press Release1 week ago
DEWEL Flea and Tick Prevention for Dogs Brings Prevention-First Care to Fleas Ticks and Mosquitoes
-
Press Release3 days ago
BILLSAS Unveils Institutional-Grade GPU Deep Quantitative Models to Enhance Global Market Execution
-
Press Release2 days ago
Your Building Team Establishes Itself as Canada’s Go-To Source for Pre-Engineered Steel Building Kits
-
Press Release6 days ago
Author Candace Nicole Releases Gripping New Psychological Thriller Tangled Roots Book One of The Root Series
-
Press Release3 days ago
Ramsey Elkholy on Creating Music That Feels Like a Journey Rather Than a Playlist